Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

New Research Published In Oncotarget Shows Inhibition Of miR-10b With MN-anti-miR10b Nanodrug Targets Stem Cell-Like Properties In Metastatic Breast Cancer, Reducing Stemness And Preventing Metastasis In Mouse Models When Combined With Chemotherapy

Author: Benzinga Newsdesk | August 28, 2024 02:16pm

https://www.eurekalert.org/news-releases/1055915

Posted In: RNAZ

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist